Log out
to your PfizerFlex
Patient Support Program
for ABRILADA
Rheumatoid Arthritis (RA)
Rheumatoid arthritis (RA) is a disease in which the immune system mistakenly attacks and damages healthy tissue in the joints. This leads to inflammation (swelling) and pain, and most commonly affects the hands, feet, wrists, elbows, knees, and ankles. Over time, if the inflammation isn’t managed, RA can lead to joint damage and deformity. RA is 3 times as common in women.
ABRILADA is used to treat adults with rheumatoid arthritis (RA).
Your immune system works to protect your body from bacteria, viruses, and other foreign agents. In RA, the immune system mistakenly recognizes the body as foreign and attacks healthy body cells.
When you have RA, your immune system overproduces a substance called TNF-alpha (which stands for tumour necrosis factor alpha). The extra TNF-alpha can attack normal healthy body tissues and cause inflammation, especially in the bones, cartilage and joints.
The way ABRILADA works is by binding to TNF-alpha and decreasing the inflammation process of RA. However, ABRILADA can also lower the body’s ability to fight infections, and taking it can make you more prone to getting infections, or make any infection worse.
ABRILADA is administered by injection under the skin, also called a subcutaneous injection.
ABRILADA ®, Pfizer Inc., owner/ Pfizer Canada ULC, Licensee
PFIZERFLEX TM, Pfizer Inc., owner/ Pfizer Canada ULC, Licensee
© 2024 Pfizer Canada ULC, Kirkland, Quebec H9J 2M5
PP-ABD-CAN-0037-EN